Synergy CHC Corp. Common Stock (SNYR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Synergy CHC Corp. Common Stock stock (SNYR) is currently trading at $1.17. Synergy CHC Corp. Common Stock PE ratio is 4.18. Synergy CHC Corp. Common Stock PS ratio (Price-to-Sales) is 0.38. Analyst consensus price target for SNYR is $6.00. WallStSmart rates SNYR as Sell.
- SNYR PE ratio analysis and historical PE chart
- SNYR PS ratio (Price-to-Sales) history and trend
- SNYR intrinsic value — DCF, Graham Number, EPV models
- SNYR stock price prediction 2025 2026 2027 2028 2029 2030
- SNYR fair value vs current price
- SNYR insider transactions and insider buying
- Is SNYR undervalued or overvalued?
- Synergy CHC Corp. Common Stock financial analysis — revenue, earnings, cash flow
- SNYR Piotroski F-Score and Altman Z-Score
- SNYR analyst price target and Smart Rating
Synergy CHC Corp.
📊 No data available
Try selecting a different time range
SNYR Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Synergy CHC Corp. Common Stock (SNYR)
SNYR is trading near its Graham intrinsic value of $1.90, suggesting the stock is reasonably priced at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Synergy CHC Corp. Common Stock (SNYR) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Synergy CHC Corp. Common Stock (SNYR) Key Strengths (2)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
Supporting Valuation Data
Synergy CHC Corp. Common Stock (SNYR) Areas to Watch (7)
Company is destroying shareholder value
Earnings declining -90.60%, profits shrinking
Very low institutional interest at 11.53%
Micro-cap company with very limited liquidity and high volatility
Thin profit margins with limited profitability
Decent operational efficiency, solid but not exceptional
Solid revenue growth at 12.40% per year
Synergy CHC Corp. Common Stock (SNYR) Detailed Analysis Report
Overall Assessment
This company scores 45/100 in our Smart Analysis, earning a D grade. Out of 9 metrics analyzed, 2 register as strengths (avg 10.0/10) while 7 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book. Valuation metrics including Price/Sales (0.38), Price/Book (0.91) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, EPS Growth, Institutional Own.. Growth concerns include Revenue Growth at 12.40%, EPS Growth at -90.60%, which may limit upside. Profitability pressure is visible in Return on Equity at -361.10%, Operating Margin at 16.00%, Profit Margin at 7.46%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -361.10% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 12.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and EPS Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SNYR Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SNYR's Price-to-Sales ratio of 0.38x trades 73% above its historical average of 0.22x (77th percentile), historically expensive. The current valuation is 83% below its historical high of 2.21x set in Oct 2024, and Infinity% above its historical low of 0x in Dec 2021. Over the past 12 months, the PS ratio has compressed from ~0.9x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Synergy CHC Corp. Common Stock (SNYR) · HEALTHCARE › MEDICAL DISTRIBUTION
The Big Picture
Synergy CHC Corp. Common Stock operates as a stable business with moderate growth and solid fundamentals. Revenue reached 35M with 12% growth year-over-year. Profit margins are thin at 7.5%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Debt-to-equity ratio of -3.04 indicates a conservative balance sheet with 1M in cash.
Free cash flow is -2M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
Earnings fell 91% YoY while revenue grew 12%. This gap usually reflects one-time items (tax benefits, write-offs) in the prior period, not an operational decline.
What to Watch Next
Margin expansion: can Synergy CHC Corp. Common Stock push profit margins above 15% as the business scales?
Debt management: total debt of 25M is significantly higher than cash (1M). Monitor refinancing risk.
Sector dynamics: monitor MEDICAL DISTRIBUTION industry trends, competitive moves, and regulatory changes that could impact Synergy CHC Corp. Common Stock.
Bottom Line
Synergy CHC Corp. Common Stock offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Synergy CHC Corp. Common Stock(SNYR)
NASDAQ
HEALTHCARE
MEDICAL DISTRIBUTION
USA
Synergy CHC Corp. The company is headquartered in Westbrook, Maine.